Prelude Capital Management, LLC Wave Life Sciences Ltd. Transaction History
Prelude Capital Management, LLC
- $1.39 Billion
- Q2 2024
A detailed history of Prelude Capital Management, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 135,200 shares of WVE stock, worth $2.22 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
135,200
Previous 144,300
6.31%
Holding current value
$2.22 Million
Previous $890,000
24.27%
% of portfolio
0.05%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding WVE
# of Institutions
148Shares Held
93.8MCall Options Held
33KPut Options Held
57.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$299 Million1.37% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.67MShares$126 Million0.75% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$111 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$101 Million35.47% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.36MShares$88.1 Million0.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.43B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...